.png)
NEW VETERINARY PRODUCTS
New Veterinary Drugs
1. Panoquell-CA1 (fuzapladib sodium)
Use: Acute pancreatitis in dogs (reduces neutrophil-driven inflammation)
First drug specifically targeting pancreatitis (not just supportive care)
Company: Ishihara Sangyo Kaisha / marketed in U.S. via DechraStatus: Conditionally FDA approved
2. Credelio Quattro (lotilaner + moxidectin + praziquantel + pyrantel)
Use: Monthly all-in-one parasite prevention (fleas, ticks, heartworm, intestinal parasites)
Broadest combo oral parasiticide → compliance driver
Company: Elanco Animal HealthStatus: FDA approved, Treatment of New World screwworm (myiasis) in dogs launched 2025
3. Zenrelia (ilunocitinib tablets)
Use: Atopic dermatitis / pruritus in dogs (JAK inhibitor class)
New competitor to Apoquel with targeted immune modulation
Company: Elanco Animal HealthStatus: Launched internationally, expanding markets in 2025
5. Numelvi (atinvicitinib tablets)
Use: Allergic dermatitis / pruritus in dogs
Expanding oral targeted therapies for allergy management
Company: (Dechra – commonly associated in pipeline/launch discussions)Status: Newly approved (recent FDA approvals list)
6. Bravecto Quantum (injectable fluralaner)
Use: Long-acting flea/tick prevention (up to ~12 months)
Major shift toward annual compliance dosing
Company: Merck Animal HealthStatus: Newly approved extended-release formulation (2025 era)
7. Lenivia (izenivetmab)
Use: Osteoarthritis pain in dogs (anti-NGF monoclonal antibody)
Expands biologic pain management beyond Librela
Company: ZoetisStatus: Approved in multiple global markets (2025 expansion)
8. Portela (relfovetmab)
Use: Osteoarthritis pain in cats (anti-NGF monoclonal antibody)
Continued expansion of feline biologics (Solensia competitor class)
Company: ZoetisStatus: Approved internationally (2025)
9.GS-441524 (FIP Antiviral)
Use: First highly effective treatment for a historically fatal disease; major shift in feline medicine toward curative antivirals
Company: Not branded (compounded / derivative of Gilead Sciences research)
Status: Available via compounding pharmacies in the U.S. (not FDA-approved veterinary drug)
New Veterinary Tests
1. IDEXX Cancer Dx™ Panel
Detects: Early lymphoma (blood test)
Can detect cancer before clinical signs → huge shift toward screening
Company: IDEXX LaboratoriesNotes: Can be added to routine wellness panels
2. Nu.Q® Vet Cancer Test (Canine + Feline)
Detects: Cancer via nucleosomes (liquid biopsy)
Non-invasive, affordable early cancer screening
Company: VolitionRxNotes:Already available for dogsFeline version emerging (major breakthrough for lymphoma detection)
3. Liquid Biopsy / ctDNA Testing (Next-Gen Oncology Diagnostics)
Detects: Tumor DNA in blood (multiple cancers)
No biopsy requiredEarlier detection + monitoring
Company: Multiple (Volition, IDEXX, emerging biotech)
4. AI-Powered Blood Diagnostic Platforms
Detects: Multi-disease patterns from bloodwork
Faster interpretationReduced human errorPredictive disease modeling
Company: Multiple (IDEXX, Zoetis, emerging AI platforms)
5. Advanced In-House Blood Analyzers (Next-Gen)
Detects: CBC, chem, endocrine, etc. with improved accuracy
Results in <30 minutesBetter decision-making in ER/urgent care
Company: IDEXX, Zoetis, Heska (industry-wide innovation)
6. LC-MS/MS Vitamin & Nutritional Assays (Upgraded Testing)
Detects: Vitamins A, E, full nutritional profiles
Much more precise than older methodsBetter for chronic disease + nutrition cases
Company: University/diagnostic labs (e.g., MSU VDL)
7. Genetic & Mutation Testing Panels (Expanded Oncology + Disease Panels)
Detects: Genetic mutations linked to cancer & disease risk
Personalized medicine for petsRisk prediction + targeted therapy
Company: IDEXX + specialty labs
8. AI-Assisted Imaging Diagnostics
Detects: Cancer, cardiomegaly, orthopedic disease via imaging
Improves accuracy of radiographs/ultrasoundHelps non-specialists interpret cases
Company: Multiple AI/diagnostic companies
9. Wearable Cardiac Monitoring (Next-Gen Holter Devices)
Detects: Arrhythmias over 24+ hours
Easier, more comfortable than traditional HoltersAI-assisted interpretation
Example: Atrio Pet Pulse device
10. Wearable Gait & Mobility Analysis (AI-driven)
Detects: Neurologic vs orthopedic lameness
Objective gait analysis (vs subjective exam)High diagnostic accuracy (~96% in studies)
Company: Emerging med-tech / research platforms